These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11475788)

  • 21. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update.
    van der Bijl P; van der Bijl P
    SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of antipyretic effect of nimesulide and paracetamol in children attending a secondary level hospital.
    Kapoor SK; Sharma J; Batra B; Paul E; Anand K; Sharma D
    Indian Pediatr; 2002 May; 39(5):473-7. PubMed ID: 12037280
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis.
    Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothermia with nimesulide.
    Sharma S
    Indian Pediatr; 2001 Jul; 38(7):799-800. PubMed ID: 11463975
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective hypersensitivity to nimesulide.
    Viola M; Maietta G; Quaratino D; Rumi G; Gaeta F; Romano A
    Allergy; 2008 May; 63(5):624-6. PubMed ID: 18394140
    [No Abstract]   [Full Text] [Related]  

  • 27. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A; Boisseau M; Yusup A; Upur H; Bégaud B; Moore N
    Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adverse effects of NSAID are insidious. No pain--despite life threatening gastric hemorrhage].
    MMW Fortschr Med; 2002 Sep; 144(37):55. PubMed ID: 12380342
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
    Nguyen A; Chaiton A
    Can Fam Physician; 2001 Jul; 47():1398-400. PubMed ID: 11494927
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)].
    Boehncke S; Boehncke WH
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2249-52. PubMed ID: 16208597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 34. Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?
    Aarntzen EH; van Riel PL; Barrera P
    Ann Rheum Dis; 2005 Oct; 64(10):1523-4. PubMed ID: 16014669
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute liver failure due to a treatment by nimesulide: another case and review].
    Page M; Christin F; Hayi-Slayman D; Baillon JJ; Ber CE; Delafosse B; Dumortier J; Rimmelé T
    Ann Fr Anesth Reanim; 2008 Sep; 27(9):742-6. PubMed ID: 18760563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
    LeLorier J; Bombardier C; Burgess E; Moist L; Wright N; Cartier P; Huckell V; Hunt R; Nawar T; Tobe S
    Can J Cardiol; 2002 Dec; 18(12):1301-8. PubMed ID: 12518182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.